Suha Halit Taspolatoglu
Chief Executive Officer presso Abdi Ibrahim Ilac Sanayi ve Tic AS
Profilo
Suha Halit Taspolatoglu is currently the Chief Executive Officer & Director at Abdi Ibrahim.
Ilac Sanayi ve Tic AS since 2013 and also a Director at Ocugen OpCo, Inc. since 2017.
He previously worked as the General Manager at Roche Diagnostics Turkey AS from 2009 to 2013 and as an Independent Director at Ocugen, Inc. from 2019 to 2021.
He also worked as a Director at Ocugen, Inc. and held the position of Director.
Dr. Taspolatoglu obtained a doctorate degree from Ankara University School of Medicine.
Posizioni attive di Suha Halit Taspolatoglu
| Società | Posizione | Inizio |
|---|---|---|
Abdi Ibrahim Ilac Sanayi ve Tic AS
 Abdi Ibrahim Ilac Sanayi ve Tic AS Pharmaceuticals: MajorHealth Technology Abdi Ibrahim Ilac Sanayi ve Tic AS operates as a pharmaceutical company. Its products include dermatologic, endocrine and metabolism, cardiovascular system, vitamins and mierals, nervous system medications. The company was founded by Abdi Ibrahim Bey in 1912 and is headquartered in Istanbul, Turkey. | Chief Executive Officer | 01/01/2013 |
| Ocugen OpCo, Inc. | Director/Board Member | 01/06/2017 |
Precedenti posizioni note di Suha Halit Taspolatoglu
| Società | Posizione | Fine |
|---|---|---|
| OCUGEN, INC. | Director/Board Member | 10/12/2021 |
Roche Diagnostics Turkey AS
 Roche Diagnostics Turkey AS Medical SpecialtiesHealth Technology Roche Diagnostics Turkey AS engages in the wholesale of medical products. It offers surgical, medical and orthopedic instruments and devices. The company was founded on May 24, 1991 and is headquartered in Istanbul, Turkey. | Corporate Officer/Principal | 01/01/2013 |
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Director/Board Member | - |
Formazione di Suha Halit Taspolatoglu
| Ankara University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OCUGEN, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Abdi Ibrahim Ilac Sanayi ve Tic AS
Abdi Ibrahim Ilac Sanayi ve Tic AS Pharmaceuticals: MajorHealth Technology Abdi Ibrahim Ilac Sanayi ve Tic AS operates as a pharmaceutical company. Its products include dermatologic, endocrine and metabolism, cardiovascular system, vitamins and mierals, nervous system medications. The company was founded by Abdi Ibrahim Bey in 1912 and is headquartered in Istanbul, Turkey. | Health Technology |
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
| Ocugen OpCo, Inc. | |
Roche Diagnostics Turkey AS
Roche Diagnostics Turkey AS Medical SpecialtiesHealth Technology Roche Diagnostics Turkey AS engages in the wholesale of medical products. It offers surgical, medical and orthopedic instruments and devices. The company was founded on May 24, 1991 and is headquartered in Istanbul, Turkey. | Health Technology |
- Borsa valori
- Insiders
- Suha Halit Taspolatoglu
